Return to Diabetes Alert Section

Data on type 2 diabetes detailed by O.S. Sanchez and co-authors



November 26th, 2007

   2007 NOV 26 -- "The epidemic of type 2 diabetes in the latter part of the 20th and early 21(st) centuries and the recognition that achieving specific glycemic goals can substantially reduce morbidity, have made effective treatment of hyperglycemia a top priority. In addition, strict control of the multiple, classical and emergent cardiovascular risk factors are also important," scientists writing in the journal Revista Clinica Espanola report.

   "Diabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. The development of new classes of blood glucose-lowering medications such as glitazones to supplement the classical therapies such as sulfonylureas and metformin has increased oral treatment options for type 2 diabetes. Combined therapy of two oral agents is the essential axis of type 2 diabetic patients," wrote O.S. Sanchez and colleagues.

   The researchers concluded: "Early insulin therapy in combined therapy is presently an option according to ADA-2007 Standards."

   Sanchez and colleagues published their study in Revista Clinica Espanola (Pharmacological recommendations in the daily metabolic control of diabetes mellitus type 2. The role of the new insulins. Revista Clinica Espanola, 2007;207(8):411-415).

   Additional information can be obtained by contacting J.S. Ruiz, Hospital Ramon & Cajal, Medical Interna Service, Unided Riesgo Cardiometab & Patol Endotelial, Carretera Colmenar, Km 91, E-28034 Madrid, Spain.

   The publisher of the journal Revista Clinica Espanola can be contacted at: Ediciones Doyma S, L, Trav de Gracia 17-21, 08021 Barcelona, Spain.

   Keywords: Spain, Madrid, Non-insulin Dependent Diabetes Mellitus, Type 2 Diabetes Mellitus.

   This article was prepared by Diabetes Week editors from staff and other reports. Copyright 2007, Diabetes Week via NewsRx.com.

Return to Diabetes Alert Section